Verona Pharma plc
VRNA
$63.32
-$2.94-4.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 401.42M | 399.76M | 336.04M | 404.60M | 254.88M |
| Total Receivables | 68.09M | 37.26M | 12.49M | 3.68M | 11.46M |
| Inventory | 7.24M | 6.25M | 4.32M | -- | -- |
| Prepaid Expenses | 11.32M | 7.57M | 7.96M | 5.43M | 3.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.96M | 2.74M | 3.44M | 2.58M | 1.88M |
| Total Current Assets | 501.03M | 453.57M | 364.25M | 416.29M | 271.84M |
|
|
|||||
| Total Current Assets | 501.03M | 453.57M | 364.25M | 416.29M | 271.84M |
| Net Property, Plant & Equipment | 2.86M | 3.15M | 2.02M | 2.29M | 2.53M |
| Long-term Investments | 545.00K | 545.00K | 545.00K | 545.00K | 545.00K |
| Goodwill | 545.00K | 545.00K | 545.00K | 545.00K | 545.00K |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.51M | 1.97M | -- | -- | -- |
| Total Assets | 525.94M | 474.24M | 381.82M | 434.12M | 289.91M |
|
|
|||||
| Total Accounts Payable | 9.08M | 11.27M | 6.83M | 4.15M | 4.65M |
| Total Accrued Expenses | 36.82M | 17.86M | 18.31M | 19.63M | 8.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.08M | 1.81M | 952.00K | 1.03M | 1.12M |
| Total Finance Division Other Current Liabilities | 9.57M | 11.75M | 1.86M | 23.53M | 736.00K |
| Total Other Current Liabilities | 9.57M | 11.75M | 1.86M | 23.53M | 736.00K |
| Total Current Liabilities | 56.54M | 42.68M | 27.95M | 48.35M | 14.77M |
|
|
|||||
| Total Current Liabilities | 56.54M | 42.68M | 27.95M | 48.35M | 14.77M |
| Long-Term Debt | 241.74M | 225.76M | 120.01M | 119.69M | 48.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.06M | 1.24M | 1.35M | 1.48M | 1.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 102.02M | 96.34M | -- |
| Total Liabilities | 299.34M | 269.68M | 251.33M | 265.85M | 64.92M |
|
|
|||||
| Common Stock & APIC | 811.39M | 773.22M | 664.40M | 659.39M | 645.27M |
| Retained Earnings | -578.79M | -562.40M | -528.48M | -485.31M | -414.40M |
| Treasury Stock & Other | -6.00M | -6.26M | -5.43M | -5.80M | -5.88M |
| Total Common Equity | 226.60M | 204.56M | 130.49M | 168.27M | 224.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 226.60M | 204.56M | 130.49M | 168.27M | 224.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 226.60M | 204.56M | 130.49M | 168.27M | 224.99M |
|
|
|||||